Log In
BCIQ
Print this Print this
 

FAS31

  Manage Alerts
Collapse Summary General Information
Company FASgen Inc.
DescriptionFatty acid synthase (FAS) inhibitor
Molecular Target Fatty acid synthase (FASN) (FAS)
Mechanism of ActionFatty acid synthase (FAS) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationOvarian cancer
Indication DetailsTreat ovarian cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today